Advanced SearchNewsfeedFollowed Companies

Fluidigm's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Fluidigm develops, manufactures and markets microfluidic systems for growth markets in the life sciences markets.

Fluidig... Read more

Based on data from Fluidigm's latest SEC filings

Annual Revenue

Based on data from Fluidigm's latest SEC filings

Employees

Chris Linthwaite's photo - President & CEO of Fluidigm

President & CEO

Chris Linthwaite

CEO Approval Rating

74/100

OVERVIEW

Founded:

1999

Headquarters:

South San Francisco, California
San Francisco Bay Area

Status:

PublicNASDAQFLDM

Industry Sector:

Biotechnology

SIC Code:

2836NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is NanoString a competitor of Fluidigm?

I don't know

Trending News for Fluidigm and Fluidigm's Competitors

May 25, 2020

Medical Buyer

Agilent reports second-quarter fiscal year 2020 financial results

Highlights: Revenue of $1.24 billion represents flat reported growth, down 1.7% on a core(1) basis GA... See more »

May 26, 2020

Clinical Lab Products

Biodesix and Bio-Rad Team Up to Launch Covid-19 Serology Test

Clinical evaluation demonstrated specificity greater than 99%, and diagnostic sensitivity of 98%, at ... See more »

May 25, 2020

NanoString Blog

Spotlight on a CRO. Q&A with Dr. Edward J. Weinstein, Ph.D., CEO and co-founder of Canopy BioSciences.

There is a lot to love in the beautiful city of St. Louis: from the quiet neighborhoods permeated wit... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Illumina is seen as one of Fluidigm's top competitors. Illumina's headquarters is in San Diego, California, and was founded in 1998. Like Fluidigm, Illumina also works within the Biotechnology industry. Illumina generates 1,692% of Fluidigm's revenue.

Cytek Biosciences is one of Fluidigm's top rivals. Cytek Biosciences was founded in 2015, and its headquarters is in Fremont, California. Cytek Biosciences competes in the Health Care Equipment industry. Cytek Biosciences has 403 fewer employees than Fluidigm.

IONPATH is Fluidigm's #3 rival. IONPATH is a Private company that was founded in null in Menlo Park, California. IONPATH competes in the field. Compared to Fluidigm, IONPATH has NaN fewer employees.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Chris Linthwaite

President & CEO

- -
535
$268.7M
$210.2M
1

Francis deSouza

President & CEO

65/100
7,300
$96M
$3.6B
2

Wenbin Jiang

Co-Founder & CEO

88/100
132
$12M
$5.5M
3

CEO

- -
- -
4

Mike McMullen

President & CEO

89/100
14,800
$2.2B
$5.2B
5

Norman Schwartz

Chairman & CEO

83/100
8,250
- -
$2.3B
6

Bradley Gray

President & CEO

89/100
476
$52.2M
$124.5M
7

Peter Dansky

CEO

73/100
189
- -
$3.5M
8

Brian McKelligon

CEO

70/100
91
$83.5M
9

Hesaam Esfandyarpour

Founder & CEO

90/100
105
$242.5M
$6M
10

Serge Saxonov

Co-Founder & CEO

86/100
584
$660.5M
$48.4M
The top 10 competitors in Fluidigm's competitive set are Illumina, Cytek Biosciences, IONPATH, Agilent, Bio-Rad, NanoString, Agena, Akoya Biosciences, GenapSys and 10X Genomics. Together they have raised over 3.3B between their estimated 33.8K employees. Fluidigm has 535 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 3,246.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$210.2M

Fluidigm's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 1.3B. Over the last four quarters, Fluidigm's revenue has decreased by 2.1%. Specifically, in Q1 2020's revenue was $27.6M; in Q4 2019, it was $32.4M; in Q3 2019, it was $26.5M; in Q2 2019, Fluidigm's revenue was $28.2M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Instrunor AS

Feb 2020

Source »
$7.2M
Instrunor is a manufacturer and supplier of flow and mass cytometry instruments for the healthcare sector.

These are all the companies that Fluidigm has acquired. Fluidigm's latest acquisition was Instrunor AS in Feb 2020. Instrunor is a manufacturer and supplier of flow and mass cytometry instruments for the healthcare sector.

Fluidigm Funding History

Since Fluidigm was founded in 1999, it has participated in 9 rounds of funding. In total Fluidigm has raised $268.7M. Fluidigm's last funding round was on Feb 2014 for a total of $76.8M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Feb 2014
$76.8M
-
IPO
Feb 2011
$75M
-
Debt
Jan 2011
$5M
-
Equity
Nov 2009
$18.5M
-
Debt
Aug 2009
$10.7M
-

Total Funding: $268.7M

Since Fluidigm was founded in 1999, it has participated in 9 rounds of funding. In total Fluidigm has raised $268.7M. Fluidigm's last funding round was on Feb 2014 for a total of $76.8M

Investments

No recent investments found related to Fluidigm

Fluidigm News

April 14, 2020marketexclusive

Fluidigm Corporation (NASDAQ:FLDM) Files An 8-K Results of Operations and Financial Condition

EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFilingEXHIBIT 99.1Fluidigm Provides Update on COVID-19 Impac... See more »
March 16, 2020Genomeweb

Mount Sinai-Led Consortium, Fluidigm Developing Epigenetic Coronavirus Dx

See more »
March 11, 2020MarketScreener

Fluidigm and SIgN Establish the First Center of Excellence in Singapore to Advance Imaging Mass Cytometry

(marketscreener.com) SOUTH SAN FRANCISCO, Calif., March 11, 2020 -- Fluidigm Corporation , an innovat... See more »
March 5, 2020Seeking Alpha

Fluidigm closes $50M stock sales deal

See more »
March 3, 2020FinanzNachrichten

Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing

Enabling Low-Cost, High-Volume Sequencing of Drug-Resistant Pathogens for Hospital Infection Control ... See more »
February 28, 2020MarketScreener

SEC Filing (POS AM)

(marketscreener.com) As filed with the Securities and Exchange Commission on February 27, 2020 Regist... See more »
February 26, 2020BioSpace

Fluidigm Completes Acquisition of InstruNor AS

Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to impr... See more »

Fluidigm Press Releases

May 7, 2020GlobalNewswire

Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services

Custom Projects and Consultation from Experimental Panel Design to Data Analysis... See more »
April 23, 2020GlobeNewswire

OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation File for FDA Emergency Use Authorization for COVID-19 Detection Test Utilizing Fluidigm Technology

Expediting Treatment of COVID-19 Patients and Enhancing Testing Resources for Caregivers in Oklahoma... See more »
April 2, 2020GlobeNewswire

Fluidigm CyTOF Technology Used to Evaluate Stem Cell Therapy as a Potential Treatment for COVID-19 Pneumonia

SOUTH SAN FRANCISCO, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), a... See more »
March 10, 2020GlobeNewswire

Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research

Driving Cell Capture to Insight with Precision, Speed and Simplicity to Accelerate Biomarker and Ther... See more »
February 12, 2020GlobeNewswire

Fluidigm to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an... See more »
February 10, 2020StreetInsider

Fluidigm Establishes Center of Excellence at NCI-Designated Comprehensive Cancer Center to Advance Imaging Mass Cytometry

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), a... See more »
February 10, 2020GlobeNewswire

Fluidigm CyTOF Technology Selected by Covance to Develop Highly Multiplexed Human Immune Profiling Services

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm (Nasdaq:FLDM) today announced... See more »

Fluidigm Videos

July 25, 2017Fluidigm Vimeo Channel

"Fluidigm_Mass_Cyto_2017_Katjia_Kleinsteuber_20170707_Disc" on VIMEO

Cast: Fluidigm... See more »
July 25, 2017Fluidigm Vimeo Channel

"Fluidigm_Mass_Cyto_2017_Introduction_20170609" on VIMEO

Cast: Fluidigm... See more »
July 25, 2017Fluidigm Vimeo Channel

"Fluidigm_Mass_Cyto_2017_Bruce_Bagwell_20170619" on VIMEO

Cast: Fluidigm... See more »
July 25, 2017Fluidigm Vimeo Channel

"Fluidigm_Mass_Cyto_2017_Alice_Wiederman_20170616" on VIMEO

Cast: Fluidigm... See more »
July 25, 2017Fluidigm Vimeo Channel

"Fluidigm_Mass_Cyto_2017_Adeeb_Rahman_20170615" on VIMEO

Cast: Fluidigm... See more »
December 14, 2016Fluidigm Youtube Channel

"Mass Cytometry in Focus" on YOUTUBE

See more »
December 17, 2015Fluidigm Vimeo Channel

"Explore-Functional-Heterogeneity-Polaris" on VIMEO

Polaris revolutionizes biology by letting you understand the unique function of every cell and the ge... See more »

Social Statistics

Headquarters

7000 Shoreline Court Suite 100

South San Francisco, California94080

1-650-266-6000

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Fluidigm develops, manufactures and markets microfluidic systems for growth markets in the life sciences markets. Fluidigm was founded in 1999. Fluidigm's headquarters is located in South San Francisco, California, USA 94080. It has raised 268.7M in 9...

CEO

Fluidigm's President & CEO, Chris Linthwaite, currently has an approval rating of 74%. Fluidigm's primary competitors are Illumina, Cytek Biosciences & IONPATH.

Website

fluidigm.com

Frequently Asked Questions about Fluidigm

  1. When was Fluidigm founded?

    Fluidigm was founded in 1999

  2. Who is Fluidigm's CEO?

    Fluidigm's CEO is Chris Linthwaite

  3. How much revenue does Fluidigm generate?

    Fluidigm generates $210.2M in revenue

  4. How much funding does Fluidigm have?

    Fluidigm has historically raised $268.7M in funding

  1. Where is Fluidigm's headquarters?

    Fluidigm's headquarters is in South San Francisco California, USA

  2. How many employees does Fluidigm have?

    Fluidigm has 535 employees

  3. What sector does Fluidigm operate in?

    Fluidigm is in Biotechnology

  4. Who are Fluidigm's competitors?

    Fluidigm's top competitors are Illumina, Cytek Biosciences, IONPATH
Stay up-to-date with the latest news on Fluidigm